株探米国株
日本語 英語
エドガーで原本を確認する
false 0000765880 0000765880 2024-04-25 2024-04-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K 

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

April 25, 2024

Date of Report (Date of earliest event reported)

 

 

 

Healthpeak Properties, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland 001-08895 33-0091377
(State or other jurisdiction of incorporation) (Commission File Number)

(IRS Employer Identification No.)

 

4600 South Syracuse Street, Suite 500

Denver, CO 80237

(Address of principal executive offices) (Zip Code)

 

(720) 428-5050

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1.00 par value DOC New York Stock Exchange

 

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 


 

 

 

Item  5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

(b)            Departure of Directors or Certain Officers

 

Christine N. Garvey and David B. Henry retired from the Board of Directors (the “Board”) of Healthpeak Properties, Inc. (the “Company”) effective immediately prior to the 2024 annual meeting of stockholders held on April 25, 2024 (the “Annual Meeting”). In connection with their retirements pursuant to the Company’s director term limit policy, the Board reduced its size from thirteen to eleven directors.

 

Item  5.07 Submission of Matters to a Vote of Security Holders.

 

At the Annual Meeting, there were present, in person or by proxy, 636,242,256 shares of the Company’s common stock, which represented approximately 89.66% of the shares entitled to vote and constituted a quorum.

 

Set forth below are the voting results for the three proposals considered and voted upon at the Annual Meeting, each of which were described in the Company’s definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on March 13, 2024.

 

Proposal 1. All of the nominees listed below were elected to the Board of Directors of the Company, each having received the affirmative vote of a majority of the votes cast.

 

    For     Against     Abstain    

Broker

Non-Votes

    % of Votes Cast Supporting  
Scott M. Brinker     582,831,626       4,068,380       479,750       48,862,500       99.31 %
Katherine M. Sandstrom     553,781,817       33,118,908       479,031       48,862,500       94.36 %
John T. Thomas     583,191,586       3,710,222       477,948       48,862,500       99.37 %
Brian G. Cartwright     578,484,811       8,390,456       504,489       48,862,500       98.57 %
James B. Connor     579,928,038       6,962,013       489,705       48,862,500       98.81 %
R. Kent Griffin, Jr.     579,229,541       7,662,898       487,317       48,862,500       98.69 %
Pamela J. Kessler     583,698,642       3,222,110       459,004       48,862,500       99.45 %
Sara G. Lewis     566,873,595       20,035,240       470,921       48,862,500       96.59 %
Ava E. Lias-Booker     583,544,342       3,331,289       504,125       48,862,500       99.43 %
Tommy G. Thompson     582,923,497       3,962,088       494,171       48,862,500       99.32 %
Richard A. Weiss     583,029,763       3,864,720       485,273       48,862,500       99.34 %

 

Proposal 2. The advisory vote to approve 2023 executive compensation was approved.

 

For   Against     Abstain     Broker Non-Votes     % of Votes Cast
Supporting
 
548,270,776     38,235,408       873,572       48,862,500       93.48 %

 

 


 

Proposal 3. The ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024, was approved.

 

For   Against     Abstain     Broker Non-Votes     % of Votes Cast
Supporting
 
620,953,588     14,829,272       459,396       N/A       97.67 %

 

 


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: April 26, 2024 HEALTHPEAK PROPERTIES, INC.
 
  By: /s/ Jeffrey H. Miller
    Jeffrey H. Miller
    General Counsel